Are natural killer cells superior CAR drivers?
Oncoimmunology
; 3: e28147, 2014.
Article
en En
| MEDLINE
| ID: mdl-25340009
ABSTRACT
T lymphocytes engineered to express a chimeric antigen receptor (CAR) are being celebrated as a major breakthrough of anticancer immunotherapy. Natural killer cells have not received similar attention as CAR effectors, although the use of these relatively short-lived cytotoxic cells is associated with several advantages.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Oncoimmunology
Año:
2014
Tipo del documento:
Article